🔎 Trials Near Me

Home › Urothelial (Transitional Cell) Carcinoma › Florida › Gainesville

Urothelial (Transitional Cell) Carcinoma clinical trials in Gainesville, FL

6 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Gainesville (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

RecruitingPhase 1
  • Exelixis Clinical Site #11, Gainesville
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT05176483

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

RecruitingPhase 3
  • UF Health Cancer Institute - Gainesville, Gainesville
Ages 18 and older · All sexes · Updated Oct 1, 2026 · NCT06524544

Nephroureterectomy With and Without Lymph Node Dissection for Upper Tract Urothelial Cell Carcinoma

Recruiting
  • University of Florida Health Science Center, Gainesville
Ages 19 and older · All sexes · Updated Oct 1, 2026 · NCT06262516

uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

RecruitingObservational study
  • University of Florida, Gainesville
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT05874921

Assessment of Decision Tool to Select Women for Gynecologic Sparing Radical Cystectomy

RecruitingPhase 2
  • University of Florida, Gainesville
Ages 18 to 99 · Women · Updated Sep 9, 2026 · NCT06184516

A Phase 3 Single-arm Study of UGN-104 for the Treatment of Low-grade Upper Tract Urothelial Cancer

RecruitingPhase 3
  • University of Florida Health (UF Health), Cancer Center, Gainesville
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06774131

Urothelial (Transitional Cell) Carcinoma trials in other cities

Other studies in Gainesville

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.